Tofacitinib Retreatment Effective for Ulcerative Colitis Tofacitinib Retreatment Effective for Ulcerative Colitis

Clinical response can be recaptured in patients who have had to interrupt treatment with tofacitinib, a JAK inhibitor, for up to 2 months, an analysis of data from the OCTAVE extension trial shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news